Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nimorazole

EU orphan designation number: EU/3/10/842   
Active ingredient: Nimorazole
Indication: Treatment of squamous cell carcinoma of the head and neck in patients undergoing radiotherapy
Sponsor: Azanta A/S
Tranegaardsvej 20, DK-2900 Hellerup, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Centralised Orphan - Designation EMA/OD/093/10 (2011)1308 of 23/02/2011